Suliman R

ORCID: 0009-0002-9607-3353 · 3 papers in corpus
observational 2026
Neurology and therapy ·doi:10.1007/s40120-026-00961-9

INTRODUCTION: Atogepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist approved for migraine prevention; however, real-world data from the Middle East and North Africa (MENA) region remain limited. This study evaluate…

observational 2026
European journal of neurology ·doi:10.1111/ene.70597

BackgroundRecent post-marketing studies have indicated a possible association between anti-CGRP receptor monoclonal antibodies (anti-CGRP-mAbs) used for migraine prophylaxis and an increased risk of hypertension (HT).MethodsWe performed a r…

other 2025
Cureus ·doi:10.7759/cureus.99926

BACKGROUND: The prostaglandin E receptor 1 (PTGER1) is a G-protein-coupled receptor (GPCR) located on chromosome 9. It encodes prostaglandin E2 receptor 1 (EP1), a 42kDa prostaglandin receptor involved in mediating many physiological and pa…